Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 1085-1088

  Hoellman, Dianne B ^a   Pankuch, Glenn A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CLARITHROMYCIN; DOXYCYCLINE; IMIPENEM; MEROPENEM; MINOCYCLINE; PENICILLIN G; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0034065855     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.1085-1088.2000     Document Type: Article

References (17)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae - an overview. Clin. Infect. Dis. 15:77-83.
2. Bergeron, J., M. Ammirati, D. Danley, L. James, M. Norcia, J. Retsema, C. A. Strick, W.-G. Su, J. Sutcliffe, and L. Wondrack. 1996. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection. Antimicrob. Agents Chemother. 40:2226-2228.
3. Eliopoulos, G. M., C. B. Wennersten, G. Cole, and R. C. Moellering. 1994. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob. Agents Chemother. 38:534-541.
4. Goldstein, F. W., M. D. Kitzis, and J. F. Acar. 1994. N,N-Dimethylglycylamido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci. Antimicrob. Agents Chemother. 38:2218-2220.
5. Hamilton-Miller, J. M. T., and S. Shah. 1996. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 37: 1171-1175.
6. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
7. Jacobs, M. R., and P. C. Appelbaum. 1995. Antibiotic-resistant pneumococci. Rev. Med. Microbiol. 6:77-93.
8. Jacobs, M. R., S. Bajaksouzian, A. Zilles, G. Lin, G. A. Pankuch, and P. C. Appelbaum. 1999. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob. Agents Chemother. 43:1901-1908.
9. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Nord, C. E., A. Lindmark, and I. Persson. 1993. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 12:784-786.
11. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
12. Pankuch, G. A., C. Lichtenberger, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob. Agents Chemother. 40:1653-1656.
13. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
14. Testa, R. T., P. J. Petersen, N. V. Jacobus, P.-E. Sum, V. J. Lee, and F. P. Tally. 1993. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob. Agents Chemother. 37:2270-2277.
15. Van Ogtrop, M. L., D. Andes, W. A. Craig, and O. Vesga. 1998. In vivo activity of two glycylcyclines (GAR-936 and WAY 152,288) against tetracycline-sensitive and -resistant bacteria, abstr. F-133, p. 266. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Weiss, W. J., N. V. Jacobus, P. J. Petersen, and R. T. Testa. 1995. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines. J. Antimicrob. Chemother. 36: 225-230.
17. Wise, R., and J. M. Andrews. 1994. In vitro activities of two glycylcyclines. Antimicrob. Agents Chemother. 38:1096-1102.